Consolidated Statement Of Income

Mochida Pharmaceutical Co.,Ltd. - Filing #7714401

Concept 2018-04-01 to
2018-12-31
2017-04-01 to
2017-12-31
Consolidated statement of income
Statement of income
Net sales
87,638,000,000 JPY
83,730,000,000 JPY
Cost of sales
44,662,000,000 JPY
40,434,000,000 JPY
Operating expenses
Selling, general and administrative expenses
31,681,000,000 JPY
31,071,000,000 JPY
Operating expenses
Gross profit (loss)
42,976,000,000 JPY
43,296,000,000 JPY
Operating profit (loss)
11,286,000,000 JPY
12,209,000,000 JPY
Net sales
Ordinary profit (loss)
11,582,000,000 JPY
12,496,000,000 JPY
Non-operating income
351,000,000 JPY
330,000,000 JPY
Dividend income
237,000,000 JPY
214,000,000 JPY
Interest income
2,000,000 JPY
2,000,000 JPY
Extraordinary income
1,557,000,000 JPY
194,000,000 JPY
Cost of sales
Non-operating income
Other
111,000,000 JPY
113,000,000 JPY
Selling, general and administrative expenses
Non-operating expenses
Interest expenses
1,000,000 JPY
3,000,000 JPY
Other
4,000,000 JPY
4,000,000 JPY
Non-operating expenses
55,000,000 JPY
43,000,000 JPY
Extraordinary losses
16,000,000 JPY
26,000,000 JPY
Gross profit
Profit (loss) before income taxes
13,123,000,000 JPY
12,665,000,000 JPY
Extraordinary income
Gain on sale of non-current assets
0 JPY
194,000,000 JPY
Extraordinary losses
Income taxes
3,274,000,000 JPY
3,394,000,000 JPY
Profit (loss)
9,849,000,000 JPY
9,270,000,000 JPY
Profit (loss) attributable to owners of parent
9,849,000,000 JPY
9,270,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
1,373,000,000 JPY
1,873,000,000 JPY
Remeasurements of defined benefit plans, net of tax
48,000,000 JPY
109,000,000 JPY
Other comprehensive income
1,421,000,000 JPY
1,982,000,000 JPY
Profit attributable to
Comprehensive income
11,271,000,000 JPY
11,252,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
11,271,000,000 JPY
11,252,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.